Systemic lupus erythematosus patients in the low-latitude plateau of China: altitudinal influences

Abstract

The current study was to investigate the features of hospitalized patients with systemic lupus erythematosus (SLE) at different altitudes. The correlation between SLE activity and altitudinal variations was also explored. Medical records of 1029 patients were retrospectively reviewed. Activity of SLE in each organ system was recorded using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). There was no significant correlation between SLE activity and altitudes (r = 0.003, p = 0.159). Age at onset for SLE patients at high altitudes was significantly younger than that at low and moderate altitudes (p = 0.022 and p = 0.004, respectively). Age at SLE admission at low altitudes was significant older than those at moderate and high altitudes (p = 0.011 and p < 0.001, respectively). Patients at high altitudes had shorter duration from disease onset to admission than those at moderate altitudes (p = 0.009). Incidence of Sm antibodies-positive for resident patients at high altitudes was 36.4%, which were higher than that at moderate altitudes (p = 0.003). We found increasing trends of CNS activity in active patients; immunological and renal activities in inactive patients were correlated with elevated altitudes (p = 0.024, p = 0.004, p = 0.005), while arthritis scores in active patients showed the tendency of decreasing with the rise of elevation (p = 0.002). Hemoglobin level, red blood cell and platelet counts at high altitudes were significantly lower than those at low altitudes (p < 0.05, respectively). There was no significant difference in hemoglobin level between moderate- and low-altitude groups (p > 0.05). No significant difference in platelet counts between moderate- and high-altitude groups was observed (p > 0.05). Our findings suggest that some clinical features, laboratory tests and activity of main organs in SLE are influenced by altitudes. Furthermore, organ activities of active and inactive SLE patients have different patterns of altitudinal variations. These distinctive variations likely reveal that peculiar environmental factors at high altitudes can affect the development of SLE.

WITHDRAWN: miR-99a-3p Targeting EIF4EBP1 Affects B Lymphocytes Function Through Autophagy and Aggravates SLE Disease Progression

“…The age of onset of SLE in high altitude areas is lower, the course of disease is shorter. The proportion of patients with Anti-Sm positive, anemia, thrombocytopenia and elevated serum creatinine is signi cantly higher than that in low altitude areas [4].…”

Clinicopathological features of pediatric renal biopsies in the plateau regions of China

“… 20 Previous studies have indicated that there are some differences in the incidence and clinical characteristics of LN at different altitudes and for different nationalities. 21 – 23 Although plateau areas are exposed to strong ultraviolet radiation, the proportion of LN in the plateau group was significantly lower than that in the non-plateau group in this cohort. This result is similar to that in a study by Zhou et al.…”

Targeting of EIF4EBP1 by miR‐99a‐3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression

“…Genetic factors influence the clinical phenotype and progression of SLE, whilst environmental factors, such as ultraviolet rays, promote the onset of SLE, 2 which play an important role in stimulating SLE 3 . The age of the onset of SLE in individuals residing in high‐altitude areas is lower, and the disease course is shorter 4 …”